Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy

Yearbook of Oncology ◽

10.1016/j.yonc.2012.06.021 ◽

2012 ◽

Vol 2012 ◽

pp. 185-186

Author(s):

A.S. Tsao

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182156250 ◽

2011 ◽

Vol 6 (6) ◽

pp. 1098-1103 ◽

Cited By ~ 42

Author(s):

Raghunadharao Digumarti ◽

Yenyun Wang ◽

Ganapathi Raman ◽

Dinesh C. Doval ◽

Suresh H. Advani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Advances in Therapy ◽

10.1007/s12325-020-01538-0 ◽

2020 ◽

Author(s):

Lowell L. Hart ◽

Renata Ferrarotto ◽

Zoran G. Andric ◽

J. Thaddeus Beck ◽

Janakiraman Subramanian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Annals of Oncology ◽

10.1023/a:1008207731111 ◽

1997 ◽

Vol 8 (6) ◽

pp. 525-529 ◽

Cited By ~ 83

Author(s):

C. Manegold ◽

B. Bergman ◽

A. Chemaissani ◽

W. Dornoff ◽

P. Drings ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Early Results

Download Full-text

32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(97)89311-7 ◽

1997 ◽

Vol 18 ◽

pp. 11 ◽

Cited By ~ 1

Author(s):

Ch. Manegold ◽

R. Stahel ◽

K. Mattson ◽

S. Ricci ◽

N.C. van Walree ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation

European Journal of Cancer ◽

10.1016/s0959-8049(11)70126-5 ◽

2011 ◽

Vol 47 ◽

pp. 14 ◽

Cited By ~ 1

Author(s):

A.M. Dinqemans ◽

W.W. Mellema ◽

H.J.M. Groen ◽

A. van Wijk ◽

S. Burgers ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Ras Mutation

Download Full-text

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70413-5 ◽

2007 ◽

Vol 2007 ◽

pp. 195-197

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Agent Treatment

Download Full-text

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90818-4 ◽

2003 ◽

Vol 1 (5) ◽

pp. S238 ◽

Cited By ~ 1

Author(s):

F. Cappuzzo ◽

S. Novello ◽

F. De Marinis ◽

M. Maur ◽

G. Scagliotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Nsclc Patients

Download Full-text

Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(96)85960-5 ◽

1996 ◽

Vol 14 (1) ◽

pp. 176-177

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Preliminary Analysis ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung

Download Full-text

A phase II study of vindesine and cisplatin (VP) used concurrently with Thoracic Radiotherapy (TRT) for locally advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(91)91937-7 ◽

1991 ◽

Vol 7 ◽

pp. 157

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

Lung Cancer ◽

10.1016/j.lungcan.2011.08.006 ◽

2012 ◽

Vol 75 (3) ◽

pp. 348-352 ◽

Cited By ~ 5

Author(s):

J.R. Fischer ◽

F. Griesinger ◽

T. Fink ◽

T. Salm ◽

A. Marseille ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung

Download Full-text